[en] OBJECTIVE: To translate and validate into Greek, the SARC-F questionnaire, a screening tool for sarcopenia. METHODS: Questionnaire was back-translated and culturally adapted into Greek according to guidelines proposed by the World Health Organization. A convenience sample of 197 Greek elderly people (71.6±7.8 years, 68.5% women) was recruited, 64 of which were classified as persons at risk of sarcopenia according to the SARC-F. Internal consistency, test-retest and inter-rater reliability were evaluated. Validity (sensitivity, specificity, predictive positive value and predictive negative value) was assessed against the definition from the European Working Group of Sarcopenia in Older People (EWGSOP2), which is considered gold standard. Receiver-operating characteristic analysis was also performed to calculate the area under the curve. RESULTS: SARC-F demonstrated high internal consistency (Cronbach's alpha of 0.93) and excellent inter-rater and test-retest reliability, with intraclass correlation coefficient (ICC) of 0.91 (95% CI 0.79-0.96), and 0.93 (95% CI 0.91-0.95), respectively. According to the definition of sarcopenia from the EWGSOP2, 53 (26.85) participants were identified as probable sarcopenic and 23 (11.6%) as sarcopenic. Sensitivity of the tool for sarcopenia was 34.4 and specificity was 93.2. Positive predictive values were 26.4 and negative predictive values were 66.6%. CONCLUSION: Τhe SARC-F was successfully adapted into Greek language. The Greek SARC-F revealed low sensitivity but high specificity with EWGSOP2 sarcopenia definitions, indicating that it can detect with precision the absence of sarcopenia.
Disciplines :
Public health, health care sciences & services
Author, co-author :
Tsekoura, Maria
Billis, Evdokia
Tsepis, Elias
Lampropoulou, Sofia
Beaudart, Charlotte ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Bruyère, Olivier ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Yilmaz, Ozlem
Bahat, Gullistan
Gliatis, John
Language :
English
Title :
Cross-cultural adaptation and validation of the Greek Version of the SARC-F for evaluating sarcopenia in Greek older adults.
Publication date :
2020
Journal title :
Journal of Musculoskeletal and Neuronal Interactions
Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019;48(1):16-31.
Tsekoura M, Billis E, Katsoulaki M, et al. Sarcopenia and its impact on quality of life a literature review. Switzerland: Springer’s Advances in Experimental Medicine and Biology (AEMB); 2017. p. 213-218.
Beaudart C, Zaaria M, Pasleau F, et al. Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis. PLoS One 2017;12(1):e0169548.
Chen L-K, Liu L-K, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2014;15:95-101.
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in older people. Age Ageing 2010;39:412-423.
Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998;147:755-763.
Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 2011;12:249-256.
Delmonico MJ, Harris TB, Lee JS, et al. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc 2007;55:769-774.
Morley JE, Cao L. Rapid screening for sarcopenia. J Cachexia Sarcopenia Muscle 2015;6(4):312-4.
Locquet M, Beaudart C, Reginster JY, et al. Comparison of the performance of five screening methods for sarcopenia. Clin Epidemiol 2017;10:71-82.
Mohd Nawi SN, Khow KS, Lim WS, et al. Screening Tools for Sarcopenia in Community-Dwellers: A Scoping Review Ann Acad Med Singapore 2019;48(7):201-216.
Malmstrom TK, Morley JE SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc 2013;14(8):531-2.
Malmstrom TK, Miller DK, Simonsick EM, et al. SARC-F: A symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle 2016;7:28-36.
Drey M, Ferrari U, Schraml M, et al. German Version of SARC-F: Translation, Adaption, and Validation. J Am Med Dir Assoc 2020 pii: S1525-8610(19)30871-0 [Epub ahead of print]
Cao L, Chen S, Zou C, et al. A pilot study of the SARC-F scale on screening sarcopenia and physical disability in the Chinese older people. J Nutr Health Aging 2014; 18(3):277-83.
Ida S, Nakai M, Ito S, et al. Association Between Sarcopenia and Mild Cognitive Impairment Using the Japanese Version of the SARC-F in Elderly Patients With Diabetes. J Am Med Dir Assoc 2017;18(9):809.e9-809.e13.
Parra-Rodríguez L, Szlejf C, García-González AI, et al. Cross-Cultural Adaptation and Validation of the Spanish-Language Version of the SARC-F to Assess Sarcopenia in Mexican Community-Dwelling Older Adults. J Am Med Dir Assoc 2016;17(12):1142-1146.
Bahat G, Yilmaz O, Kılıç C, et al. Performance of SARC-F in Regard to Sarcopenia Definitions, Muscle Mass and Functional Measures. J Nutr Health Agin 2018;22(8):898-903.
Beaudart C, Locquet M, Bornheim S, et al. French translation and validation of the sarcopenia screening tool SARC-F. Eur Geriatr Med 2018;9:29-37.
Kim S, Kim M, Won CW. Validation of the Korean Version of the SARC-F Questionnaire to Assess Sarcopenia: Korean Frailty and Aging Cohort Study. J Am Med Dir Assoc 2018;19(1):40-45.e1
Nguyen TN, Nguyen AT, Khuong LQ, Nguyen TX, Nguyen HTT, Nguyen TTH, Hoang MV, Pham T, Nguyen TN, Vu HTT. Reliability and Validity of SARC-F Questionnaire to Assess Sarcopenia Among Vietnamese Geriatric Patients. Clin Interv Aging 2020;15:879-886.
Bahat G, Yilmaz O, Oren MM, et al. Cross-cultural adaptation and validation of the SARC-F to assess sarcopenia: methodological report from European Union Geriatric Medicine Society Sarcopenia Special Interest Group. Eur Geriatr Med Springer International Publishing 2018;9(1):23-8.
Tsekoura M. Billis E, Gliatis J, et al. Cross cultural adaptation of the Greek Sarcopenia Quality of Life (SarQoL®). Disabil and Rehabil 2018;19:1-7.
Beaudart C, Biver E, Reginster JY, et al. Development of a self-administrated quality of life questionnaire for sarcopenia in elderly subjects: the SarQoL. Age Ageing 2015;44:960-966.
Folstein MF, Folstein SE, Mc Hugh PR. Mini Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
WHO (2010) Process of translation and adaptation of instruments: World Health Organization. 2010 http://www.who.int/substance:abuse/research_tools/translation/en/. Accessed 11 May 2010
Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the aged: the index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963;185:914-919.
Lawton MP, Brody EM. Assessment of older people: self maintaining and instrumental activities of daily living. Gerontologist 1969;9:179-186.
Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 1992;40:922-93.
Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001;33:337-34.
Tsekoura M, Billis E, Tsepis E, et al. The effects of group and home-based exercise programmes in elderly with sarcopenia: a randomized controlled trial. J Clin Med 2018;26:7(12).
Bahat G, Tufan A, Tufan F, et al. Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition. Clin Nutr 2016;35:1557-1563.
Terwee CB, Bot SDM, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007;60:34-42.
Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures statistics and strategies for evaluation. Control Clin Trials 1991; 12:142S-158S 24. 5.
Trevethan R. Sensitivity, Specificity, and Predictive values: Foundations, Propabilities, and Pitfalls in Research and Practice. Front Public Health 2017;5:307.
Linden A. Measuring diagnostic and predictive accuracy in disease management: an introduction to receiver operating characteristic (ROC) analysis. J Eval Clin Pract 2006;12:132-139.
Cohen J. The significance of a product moment rs. In: Statistical power analysis for the behavioral sciences, 2nd ed. Hillsdale: Lawrence Erlbaum, 1988;75-107.
Grimes DA, Schulz KF. Uses and abuses of screening tests. Lancet 2002;359:881-884.
Woo J, Leung J, Morley JE. Validating the SARC-F: a suitable community screening tool for sarcopenia? J Am Med Dir Assoc 2014;15:630-634.
Kemmler W, Sieber C, Freiberger E, et al. The SARC-F Questionnaire: diagnostic overlap with established Sarcopenia definitions in older German Men with Sarcopenia. Gerontology 2017;63:411-416.
Goodman MJ, Ghate SR, Mavros P, et al. Development of a practical screening tool to predict low muscle mass using NHANES 1999-2004. J Cachexia Sarcopenia Muscle 2013;4:187-197.
Ishii S, Tanaka T, Shibasaki K, et al. Development of a simple screening test for sarcopenia in older adults. Geriatr Gerontol 2014; Int 14(Suppl):93-101.
Yu S, Appleton S, Chapman I, et al. An anthropometric prediction equation for appendicular skeletal muscle mass in combination with a measure of muscle function to screen for sarcopenia in primary and aged care. J Am Med Dir Assoc 2015;16:25-30.
Guyatt GH, Deyo RA, Charlson M, et al. Responsiveness and validity in health status measurement: A clarification. J Clin Epidemiol 1989;42:403-408.